MacBeath Gavin 4
4 · TScan Therapeutics, Inc. · Filed Feb 11, 2025
Insider Transaction Report
Form 4
MacBeath Gavin
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-03+800,000→ 800,000 totalExercise: $3.06Exp: 2035-01-03→ Voting Common Stock (800,000 underlying) - Award
Stock Option (Right to Buy)
2024-01-12+160,000→ 160,000 totalExercise: $6.00Exp: 2034-01-12→ Voting Common Stock (160,000 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 12, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.
- [F2]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.